Learning Lounge:
New data for TEFLARO (ceftaroline fosamil) (Not Official IDWeek Programming - Supported by Actavis - See Affiliated Event Guide)
Friday, October 9, 2015: 11:15 AM-12:00 PM
Room: IDExpo Hall, Learning Lounge 2 (Booth 133)

Learning Objectives:

Presenter:

David Melnick, M.D.

Vice President of Clinical Development

Actavis

Jersey City, New Jersey

 

Learning Lounge Summary:

This program will provide an overview of new data for TEFLARO (ceftaroline fosamil), including full indications, usage, and important safety information.  This program will also detail an update to TEFLARO’s dosing and administration.

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:


See more of: Learning Lounge

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.